(immunology) A phospholipid released by leukocytes that causes aggregation of platelets and other effects, such as an increase in vascular permeability and bronchoconstriction. Abbreviated PAF.
| Sci-Tech Dictionary: platelet-activating factor |
(immunology) A phospholipid released by leukocytes that causes aggregation of platelets and other effects, such as an increase in vascular permeability and bronchoconstriction. Abbreviated PAF.
| 5min Related Video: Platelet-activating factor |
| Medical Dictionary: platelet-aggregating factor |
A substance released from rabbit basophilic white blood cells that causes aggregation of platelets and is involved in the deposition of immune complexes. Also called platelet-activating factor.
| Wikipedia: Platelet-activating factor |
| Platelet-activating factor | |
|---|---|
| Identifiers | |
| CAS number | 74389-68-7 |
| PubChem | 108156 |
| MeSH | Platelet+Activating+Factor |
| Properties | |
| Molecular formula | C26H54NO7P |
| Molar mass | 523.68 g mol−1 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
| Infobox references | |
Platelet-activating factor, also known as a PAF, PAF-acether or AGEPC (acetyl-glyceryl-ether-phosphorylcholine) is a potent phospholipid activator and mediator of many leukocyte functions, including platelet aggregation, inflammation, and anaphylaxis.
It is produced in response to specific stimuli by a variety of cell types, including neutrophils, basophils, platelets, and endothelial cells.
Contents |
Several molecular species of platelet-activating factor have been identified which vary in the length of the O-alkyl side chain.
It is an important mediator of bronchoconstriction.
It causes platelets to aggregate and blood vessels to dilate. Thus it is important to the process of hemostasis. At a concentration of 10^-12 M, PAF causes life threatening inflammation of the airways to induce asthma like symptoms.
Toxins such as fragments of destroyed bacteria induce the synthesis of PAF, which causes a drop in blood pressure and reduced volume of blood pumped by the heart, which leads to shock and maybe death.
It was discovered by French immunologist Jacques Benveniste in the early 1970s.[1][2] Its structure was elucidated by Constantinos A. Demopoulos in 1979.[3]
PAF is biosynthesized from lysophosphatidylcholine (LPC) and acetyl CoA by the enzyme LPC acetyltransferase (LPCAT).
It is degraded (thereby terminating its capacity to act as a signaling molecule) by a group of enzymes called PAF acetylhydrolases (PAFAHs) which are related to phospholipase A2.
|
||||||||
|
||||||||
| This cell biology article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
| PAF | |
| Dementia: Alternative treatment | |
| Ginkgo Biloba: Purpose |
Copyrights:
![]() | Sci-Tech Dictionary. McGraw-Hill Dictionary of Scientific and Technical Terms. Copyright © 2003, 1994, 1989, 1984, 1978, 1976, 1974 by McGraw-Hill Companies, Inc. All rights reserved. Read more | |
![]() | Medical Dictionary. The American Heritage® Stedman's Medical Dictionary Copyright © 2002, 2001, 1995 by Houghton Mifflin Company. Read more | |
![]() | Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Platelet-activating factor". Read more |
Mentioned in